RxDoctor Payments Data

Cara Crawford-Bartle, MD

Family Medicine · Mount Pleasant, MINPI 1982139382

Payments from drug & device makers

$277in general payments, 2019–2025

Across 16 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$85
  • AbbVie$59
  • Novo Nordisk$34
  • AstraZeneca$21
  • Xeris Pharmaceuticals, Inc.$18
  • Bayer$17
  • plus $43 from 3 others

What the payments were for

  • Food & beverage$277100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$277 in reported general payments places this provider in the 50th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$1,712
Medicare patients
69
Services billed
135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide109$173,303
OzempicSemaglutide87$162,111
FarxigaDapagliflozin Propanediol103$105,407
EliquisApixaban69$90,998
Trelegy ElliptaFluticasone/Umeclidin/Vilanter68$84,681
JardianceEmpagliflozin40$53,748
JanuviaSitagliptin Phosphate30$40,206
XareltoRivaroxaban20$19,746
LinzessLinaclotide15$17,443
SymbicortBudesonide/Formoterol Fumarate30$12,633
Spiriva RespimatTiotropium Bromide11$11,058
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$8,050
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$7,882
Albuterol Sulfate HfaAlbuterol Sulfate185$7,798
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$5,765

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$85$173,303109 claims
Novo NordiskOzempic$34$162,11187 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$21$125,921144 claims
AbbVieLinzess$59$17,44315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Mount Pleasant

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →